C3 and rheumatoid arthritis: Synovial fibroblasts play a key role in joint destruction in chronic RA inflammation, becoming primed by repeated challenges such as MSU or zymosan, leading to mTORC1-dependent metabolic reprogramming through the activation of complement C3 and its receptor C3a, ultimately driving a proinflammatory state83.